Current status and recent advances in reirradiation of glioblastoma

Despite aggressive management consisting of maximal safe surgical resection followed by external beam radiation therapy (60 Gy/30 fractions) with concomitant and adjuvant temozolomide, approximately 90% of WHO grade IV gliomas (glioblastomas, GBM) will recur locally within 2 years. For patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Minniti, Giuseppe, Niyazi, Maximilian, Alongi, Filippo, Navarria, Piera, Belka, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890828/
https://www.ncbi.nlm.nih.gov/pubmed/33602305
http://dx.doi.org/10.1186/s13014-021-01767-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890828/
https://www.ncbi.nlm.nih.gov/pubmed/33602305
http://dx.doi.org/10.1186/s13014-021-01767-9

Ejemplares similares